Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodPrime Therapeutics reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 3 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Health Issues8/8
- Medicare/Medicaid8/8
- Pharmacy8/8
- Trade (domestic/foreign)3/8
- Budget/Appropriations1/8
Bills named in the filings 27 bills, this period
- H.R. 2214 DRUG Act12 filings
- S. 891 Bipartisan Health Care Act8 filings
- H.R. 10445, 118th Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 Broad bill6 filings
- S. 2355 Patients Deserve Price Tags Act5 filings
- H.R. 5378, 118th Lower Costs, More Transparency Act Broad bill5 filings
22 more, 9 named in only one filing · Show all 27
- S. 1954 / H.R. 5526 Biosimilar Red Tape Elimination Act4 filings
- S. 526 Pharmacy Benefit Manager Transparency Act of 20254 filings
- H.R. 1227 Alternatives to PAIN Act3 filings
- H.R. 8143 Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.3 filings
- S. 3822 Break Up Big Medicine Act3 filings
- H.R. 7148 Consolidated Appropriations Act, 2026 Broad bill3 filings
- H.R. 4317 PBM Reform Act of 20252 filings
- H.R. 6703 Lower Health Care Premiums for All Americans Act2 filings
- H.R. 9096, 118th Pharmacists Fight Back Act2 filings
- H.R. 9393 Lower Costs, More Transparency Act of 20262 filings
- S. 3345 PBM Price Transparency and Accountability Act2 filings
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill2 filings
- S. 1339, 118th Pharmacy Benefit Manager Reform Act Broad bill2 filings
- H.R. 10050, 118th To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.1 filing
- H.R. 4231 Treat and Reduce Obesity Act of 20251 filing
- H.R. 4507, 118th Transparency in Coverage Act1 filing
- H.R. 9096 Deport the Terrorists Act of 20261 filing
- S. 2305 FRONT Act1 filing
- S. 2305, 118th Biosimilar Red Tape Elimination Act1 filing
- S. 3159 / H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act1 filing
- S. 832 EPIC Act of 20251 filing
- H.R. 3561, 118th PATIENT Act of 2023 Broad bill1 filing
From the filings
“Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); S. 2355-Patients Deserve Price Tag Act.”
“Issues related to Pharmacy Benefit Managers and Medicare Part D.”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- HHS
- DOL
The House and Senate appear in every quarter; agencies in 7 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Prime Therapeutics, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 29 sitting members of Congress in 2025–26.
See every candidate and member Prime Therapeutics gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in